Featured Research

from universities, journals, and other organizations

IUD Is Most Popular Long-acting Contraceptive Amongst Europeans

Date:
November 11, 2009
Source:
FECYT - Spanish Foundation for Science and Technology
Summary:
A European study has defined the profile for the usage of long-acting contraceptive methods. The work shows, amongst other things, that 10 percent of women use these methods, the majority over 30 years old.

New research finds that the IUD is the most popular long-acting contraceptive amongst Europeans.
Credit: SINC

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynaecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.

Related Articles


"Long-acting contraceptives (the IUD, contraceptive injection or contraceptive implant) are still not widely used," Sergio Haimovich, researcher at the Hospital del Mar in Barcelona and author of the study published in the European Journal Of Contraception And Reproductive Health Care, explains.

After the male condom, the pill is the most popular contraceptive method amongst European women, while intrauterine contraception (copper IUD or hormone-releasing IUS) is most popular as a long-term solution. Of the more than 11,000 women surveyed in 14 European countries, longer-lasting methods were used by 1,088 women, 10% of the sample.

The Spanish research, part of a broader study on the general contraceptive profile of European women, evaluates the use of long-acting reversible contraceptives. According to Haimovich, "those using them are women over the age of 30 who do not want more children and who are looking for a long-term solution." Younger girls use different methods, according to the expert.

The reasons why certain contraceptive methods are chosen, and how, are unknown. But why is there a scientific interest in the user profile? "The answers to these questions can help us to formulate contraceptive advice that is better adapted to the needs of the users," explains Haimovich.

The condom triumphs in Spain

The data consider the specific needs of each country. Spain is one of the European countries where the condom is used most, by all ages. However, according to the study hormonal methods, such as the pill or the ring, are increasingly being used.

The results of this research, awarded best work at the National Congress of Gynaecology on 25 September this year, "help to explain what users want and enable a more appropriate contraceptive check to be created," affirms Haimovich. "That is why we must always adapt our discourse to the demands of the users, and work such as this makes us aware of these requirements," the scientist points out.


Story Source:

The above story is based on materials provided by FECYT - Spanish Foundation for Science and Technology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sergio Haimovich. Profile of long-acting reversible contraception users in Europe. European Journal Of Contraception And Reproductive Health Care, 2009

Cite This Page:

FECYT - Spanish Foundation for Science and Technology. "IUD Is Most Popular Long-acting Contraceptive Amongst Europeans." ScienceDaily. ScienceDaily, 11 November 2009. <www.sciencedaily.com/releases/2009/10/091028134635.htm>.
FECYT - Spanish Foundation for Science and Technology. (2009, November 11). IUD Is Most Popular Long-acting Contraceptive Amongst Europeans. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2009/10/091028134635.htm
FECYT - Spanish Foundation for Science and Technology. "IUD Is Most Popular Long-acting Contraceptive Amongst Europeans." ScienceDaily. www.sciencedaily.com/releases/2009/10/091028134635.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins